UCATh: McMaster Catheterization for Thoracoscopic Surgery Study

Sponsor
McMaster University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02640326
Collaborator
(none)
0
1
2

Study Details

Study Description

Brief Summary

It is common practice to insert a Foley catheter into the bladder to drain urine during and after a lung resection. Recently, there has been increasing interest in the potential risks associated with this catheterization, particularly with regard to infection. As thoracic surgery adopts minimally invasive surgical techniques, the need for urinary catheterization during surgery is being questioned since these less invasive surgeries are known to result in less post-operative acute pain, shorter length of stay, and other outcomes that tend to decrease overall anesthetic needs for this patient population. Thus, there is a need to investigate whether patients who have had a minimally invasive lung resection truly need the Foley catheter at all. This will be achieved by assigning patients to either an experimental no-catheter group or the standard of care routine urinary catheter group to determine if patients with no catheter experience different rates of complications. This pilot study will primarily determine if there is a difference in post operative urinary complications between the groups. It is hoped that this study will definitively determine whether a Foley urine catheter is a necessary procedure in the course of a minimally invasive lung resection.

Condition or Disease Intervention/Treatment Phase
  • Other: No Foley Urinary Catheter
  • Other: Standard of care Foley urinary catheter insertion
N/A

Detailed Description

Urinary catheterization is standard practice during and shortly after lung resections. The standard practice is being questioned in an era where unnecessary interventions are being re-considered, particularly since urinary catheterization is not without a risk of adverse events. The study is being done to establish an evidence base to support widespread discontinuation or continuation of this standard practice. Consenting patients will be randomized to either the catheterized or non-catheterized arms. Patient urinary management will be managed as per an a priori-defined protocol that follows St. Joseph's Healthcare Hamilton (SJHH) institutional standards.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
A Prospective Randomized Control Trial Comparing Routine Urinary Catheterization vs. No-Urinary Catheterization at the Time of Thoracoscopic Pulmonary Resection (McMaster Catheterization for Thoracoscopic Surgery Study - UCATh Study)
Actual Study Start Date :
Dec 1, 2018
Actual Primary Completion Date :
Dec 1, 2018
Actual Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Active Comparator

The catheterized arm will have Standard of care Foley urinary catheter insertion according to usual institutional care pathways in the operating room prior to surgery initiation. The urinary catheter will be assessed for removal on the morning of post-operative day 1, and patients will be monitored for urinary complications once catheter is removed until patient has successfully voided spontaneously within 8 +/- 2 hours.

Other: No Foley Urinary Catheter
No Foley urinary catheter will be put in place during the operation
Other Names:
  • Experimental Comparator
  • Experimental: Experimental Arm

    The non-catheterized arm will have standard of care Foley urinary catheter insertion, with no Foley Urinary Catheter inserted prior to, during, or after surgery unless the patient is showing signs of urinary retention after surgery. Patient will be monitored for urinary complications starting in the recovery room until patient has successfully voided spontaneously within 8 +/- 2 hours

    Other: Standard of care Foley urinary catheter insertion
    A Foley urinary catheter will be put in place during the operation
    Other Names:
  • Active Comparator
  • Outcome Measures

    Primary Outcome Measures

    1. Postoperative urinary complications [From the time of surgery to post-operative Day 14.]

      Compating the difference in the rate of the occurrence of one or more of postoperative urinary tract infection, postoperative urinary retention requiring 1 catheterization, and postoperative urinary retention requiring more than 1 catheterization between the catheterized and the non-catheterized arms

    Secondary Outcome Measures

    1. Length of Hospital Stay [During patient hospital stay (Estimated to be between post-operative day 0 and day 7)]

      Comparing the total length of hospital stay between the catheterized and non-catheterized arms

    2. Rate of Post-operative Hypotension [During patient hospital stay (Estimated to be between post-operative day 0 and day 7)]

      Post-operative hypotension will be defined as systolic blood pressure less than 80 mmHg for > 6 hours requiring active fluid resuscitation. The comparison will be made of rate of occurrence between the catheterized and non-catheterized arms to account for varied volumes of fluid intake that may confound observations

    3. Total IV fluid administration [First 48 hours of the perioperative period]

      The comparison will be made of rate of occurrence between the catheterized and non-catheterized arms to account for varied volumes of fluid intake that may confound observations

    4. Validity of the bladder scanner tool relative to actual urine output [During patient hospital stay (Estimated to be between post-operative day 0 and day 7)]

      In patients who underwent a bladder scan for suspected urinary retention (Failure to pass urine within 8 +/-2 hours of de-catheterization or after surgery), it is necessary to measure how accurate the bladder scan procedure is relative to the actual amount of urine in the bladder. The bladder scanner will generate an estimate of the amount of urine in the bladder, but the accuracy is not known. The volume of urine collected from the catheter by nursing staff or as measured from a urine collection hat and compared to the reading from the bladder scanner

    5. Rate of peri-operative pulmonary complications [During patient hospital stay (Estimated to be between post-operative day 0 and day 7)]

      Pulmonary complications defined as Grade II or greater according to the Ottawa Thoracic Morbidity and Mortality (TM&M) scale (requiring treatment). The comparison will be made of rate of complication occurrence between the catheterized and non-catheterized arms

    6. Rate of peri-operative cardiac complications [During patient hospital stay (Estimated to be between post-operative day 0 and day 7)]

      Cardiac complications defined as Grade I or greater according to the Ottawa Thoracic Morbidity and Mortality (TM&M) scale (no treatment required). The comparison will be made of rate of complication occurrence between the catheterized and non-catheterized arms

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Must undergo minimally invasive Video-Assisted Thoracoscopic Thoracic Surgery (VATS) or Robotic-Assisted Thoracoscopic Thoracic Surgery (RTS) anatomic pulmonary resection surgery (lobectomy, segmentectomy)

    • Must be diagnosed with primary or secondary lung cancer eligible for resection

    Exclusion Criteria:
    • Patients who are unwilling to comply with study procedures

    • Patients who are unable to complete questionnaires with assistance

    • Non-VATS/RTS pulmonary resection patients

    • Non-anatomic pulmonary resection

    • Patients with benign disease

    • Patients requiring chronic urinary catheterization

    • Patients with contraindications to placement of urinary catheter

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Joseph's Healthcare Hamilton Hamilton Ontario Canada L8N 4A6

    Sponsors and Collaborators

    • McMaster University

    Investigators

    • Principal Investigator: John Agzarian, MD, MPH, FRCSC, McMaster University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    McMaster University
    ClinicalTrials.gov Identifier:
    NCT02640326
    Other Study ID Numbers:
    • SJHH_UCATh
    First Posted:
    Dec 28, 2015
    Last Update Posted:
    Dec 21, 2018
    Last Verified:
    Dec 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by McMaster University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 21, 2018